Obecure intends to validate the safety and therapeutic efficacy of Histalean^® for mitigation of side effects due to antipsychotic drugs through Phase II clinical trials.

For more advanced clinical studies, the company intends to seek partnerships and collaborations with major pharmaceutical companies that have established capacity in commercialization.